发明名称 SOLID FORM OF ABIRATERONE ACETATE
摘要 Combinations of (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate (Abiraterone acetate) with acidic substances such as citric acid, ascorbic acid, methyl-4-hydroxy benzoate, saccharin, vanillic acid, adipic acid, maleic acid, malic acid, tartaric acidare useful as pharmaceutical preparations and show improved properties such as aqueous solubility and dissolution kinetics, especially in the form of cocrystals or their combination with a suitable acid.
申请公布号 US2016303143(A1) 申请公布日期 2016.10.20
申请号 US201415103146 申请日期 2014.12.09
申请人 BASF SE 发明人 CHIODO Tiziana;SALVADOR Beate;VOSSEN Marcus;HAFNER Andreas;HINTERMANN Tobias;SZELAGIEWICZ Martin;BLATTER Fritz;VIERTELHAUS Martin;WEISHAAR Walter
分类号 A61K31/58;C07J43/00 主分类号 A61K31/58
代理机构 代理人
主权项 1. A pharmaceutical composition, comprising: (3β)-17-(pyridin-3-yl)androsta-5,16-dien-3-yl acetate; and at least one pharmaceutically acceptable organic acid, which is solid at standard conditions and has pKa of less than 5.0.
地址 Ludwigshafen DE